Ontology highlight
ABSTRACT: Background
Studies have shown an association of the UNC5D gene with kidney and bladder cancer and neuroblastoma. We investigated whether UNC5D acts as a tumor suppressor in papillary thyroid carcinoma (PTC).Methods
Primary PTC tumors and matched normal thyroid tissues were obtained from 112 patients to detect UNC5D mRNA by real-time PCR. Genomic DNA sequencing was performed to detect BRAF mutation in PTC tumors. The association between UNC5D expression and clinicopathological data from PTC patients was reviewed retrospectively. PTC-derived cancer cell lines TPC-1 and K1 with stable transfection of UNC5D were used to investigate the functions of UNC5D. Flow cytometry, CCK-8, Transwell assay and scratch tests were used to examine cell cycle distribution, proliferation and migration.Results
The expression of UNC5D was significantly decreased in PTC compared with adjacent normal thyroid tissues. Lower UNC5D expression was significantly associated with aggressive tumor behaviors, such as lymph node metastasis and BRAF mutation. Overexpression of UNC5D significantly suppressed malignant cell behaviors, including cell proliferation and migration, as well as tumor growth in vivo.Conclusions
These findings suggest a potential tumor suppressor role of UNC5D in PTC progression; and provide insight into potential clinical relevance for the prognosis of PTC.
SUBMITTER: Zhang MM
PROVIDER: S-EPMC5707086 | biostudies-literature | 2017 Nov
REPOSITORIES: biostudies-literature
Zhang Man-Man MM Sun Feng F Cui Bing B Zhang Le-Le LL Fang Ya Y Li Yan Y Zhang Rui-Jia RJ Ye Xiao-Ping XP Ma Yu-Ru YR Han Bing B Song Huai-Dong HD
Oncotarget 20171010 56
<h4>Background</h4>Studies have shown an association of the <i>UNC5D</i> gene with kidney and bladder cancer and neuroblastoma. We investigated whether <i>UNC5D</i> acts as a tumor suppressor in papillary thyroid carcinoma (PTC).<h4>Methods</h4>Primary PTC tumors and matched normal thyroid tissues were obtained from 112 patients to detect <i>UNC5D</i> mRNA by real-time PCR. Genomic DNA sequencing was performed to detect <i>BRAF</i> mutation in PTC tumors. The association between <i>UNC5D</i> exp ...[more]